- Home
- DNA
as 11-22-2024 4:00pm EST
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 423.5M | IPO Year: | N/A |
| Target Price: | $37.80 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Hold | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -12.86 | EPS Growth: | N/A |
| 52 Week Low/High: | $5.26 - $75.20 | Next Earning Date: | 11-12-2024 |
| Revenue: | $217,951,000 | Revenue Growth: | -30.81% |
| Revenue Growth (this year): | -25.49% | Revenue Growth (next year): | 12.85% |
Latest Ginkgo Bioworks Holdings Inc. News
DNA Breaking Stock News: Dive into DNA Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 days ago
Ginkgo Bioworks Holdings Third Quarter 2024 Earnings: Beats Expectations
PR Newswire
10 days ago
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
PR Newswire
11 days ago
Ginkgo Bioworks Advances Collaboration with Merck to Improve Biologics Manufacturing
PR Newswire
18 days ago
Ginkgo Bioworks Announces Date of Third Quarter 2024 Results Presentation
Simply Wall St.
20 days ago
With 48% ownership, Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has piqued the interest of institutional investors
PR Newswire
2 months ago
NOVUS Leverages Ginkgo Bioworks to Develop Innovative Feed Additives for Animal Agriculture
PR Newswire
2 months ago
Ginkgo Bioworks Launches Ginkgo Datapoints to Transform AI Model Training in Biology
PR Newswire
2 months ago
Ginkgo Bioworks Launches New Protein LLM and Model API Built on Google Cloud Technology
Compare DNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DNA Ginkgo Bioworks Holdings Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.